News & Events about Sage Therapeutics Inc.
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer, Barry Greene, will discuss the Companys progress in developing a leading brain health pipeline at the 41st Annual J.P. Morgan...
Business Wire
2 months ago
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022, at 8:00 a.m. ET in New York, NY. A live...
Ticker Report
2 months ago
StockNews.com cut shares of Sage Therapeutics (NASDAQ:SAGE Get Rating) from a hold rating to a sell rating in a research note issued to investors on Friday morning. Other equities analysts have also issued research reports about the company. BMO Capital Markets lowered their price target on ...
StockNews.com cut shares of Sage Therapeutics (NASDAQ:SAGE Get Rating) from a hold rating to a sell rating in a report issued on Friday morning. Several other brokerages have also recently issued reports on SAGE. Loop Capital started coverage on Sage Therapeutics in a report on Tuesday, November 1st...